AKT1 and cancer: Hyperactivation of mTORC1 due to mutation of its upstream oncogenic pathways, including the PI3K/AKT and RAS/RAF/MEK/ERK pathways, is present in numerous human cancers and mainly involved in tumor growth and survival [29].